Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Exploring the association between atypical neuroleptic agents and diabetes mellitus in older adults.

Etminan M, Streiner DL, Rochon PA.

Pharmacotherapy. 2003 Nov;23(11):1411-5.

PMID:
14620387
2.

Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

J Clin Psychiatry. 2006 Jul;67(7):1055-61.

PMID:
16889448
3.

Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

Pharmacotherapy. 2007 Jan;27(1):27-35.

PMID:
17192159
4.

Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine.

Fuller MA, Shermock KM, Secic M, Grogg AL.

Pharmacotherapy. 2003 Aug;23(8):1037-43.

PMID:
12921249
5.

Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study.

Chatterjee S, Chen H, Johnson ML, Aparasu RR.

Am J Geriatr Pharmacother. 2012 Apr;10(2):83-94. doi: 10.1016/j.amjopharm.2011.10.006. Epub 2012 Feb 10.

PMID:
22306198
6.

Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.

Østbye T, Curtis LH, Masselink LE, Hutchison S, Wright A, Dans PE, Schulman KA, Krishnan RR.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):407-15.

PMID:
15372671
7.

Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose, and specialist contact.

Bronskill SE, Anderson GM, Sykora K, Wodchis WP, Gill S, Shulman KI, Rochon PA.

J Am Geriatr Soc. 2004 May;52(5):749-55.

PMID:
15086656
8.

Diabetes mellitus and antipsychotic treatment in the United Kingdom.

Carlson C, Hornbuckle K, DeLisle F, Kryzhanovskaya L, Breier A, Cavazzoni P.

Eur Neuropsychopharmacol. 2006 Jul;16(5):366-75. Epub 2005 Dec 13.

PMID:
16356695
9.

Atypical antipsychotics and parkinsonism.

Rochon PA, Stukel TA, Sykora K, Gill S, Garfinkel S, Anderson GM, Normand SL, Mamdani M, Lee PE, Li P, Bronskill SE, Marras C, Gurwitz JH.

Arch Intern Med. 2005 Sep 12;165(16):1882-8.

PMID:
16157833
10.

Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.

Lambert BL, Chou CH, Chang KY, Tafesse E, Carson W.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):417-25.

PMID:
15786516
12.

The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis.

Caro JJ, Ward A, Levinton C, Robinson K.

J Clin Psychiatry. 2002 Dec;63(12):1135-9.

PMID:
12523873
13.

Frequency of new-onset diabetes mellitus and use of antipsychotic drugs among Central Texas veterans.

Barner JC, Worchel J, Yang M.

Pharmacotherapy. 2004 Nov;24(11):1529-38. Review.

PMID:
15537558
15.
16.

Antihypertensive therapy and incidence of type 2 diabetes in an elderly cohort.

Padwal R, Mamdani M, Alter DA, Hux JE, Rothwell DM, Tu K, Laupacis A.

Diabetes Care. 2004 Oct;27(10):2458-63.

PMID:
15451916
17.

Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia.

Lambert BL, Cunningham FE, Miller DR, Dalack GW, Hur K.

Am J Epidemiol. 2006 Oct 1;164(7):672-81. Epub 2006 Aug 30.

18.

Antipsychotic drug use and mortality in older adults with dementia.

Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA.

Ann Intern Med. 2007 Jun 5;146(11):775-86.

PMID:
17548409
19.

Incident diabetes associated with antipsychotic use in the United Kingdom general practice research database.

Kornegay CJ, Vasilakis-Scaramozza C, Jick H.

J Clin Psychiatry. 2002 Sep;63(9):758-62.

PMID:
12363114
20.

Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents.

Liperoti R, Pedone C, Lapane KL, Mor V, Bernabei R, Gambassi G.

Arch Intern Med. 2005 Dec 12-26;165(22):2677-82.

PMID:
16344428
Items per page

Supplemental Content

Write to the Help Desk